Korean Circ J.
1971 Dec;1(2):43-48. 10.4070/kcj.1971.1.2.43.
Propranolol Hcl in Patients with Angina Pectoris
- KMID: 2229705
- DOI: http://doi.org/10.4070/kcj.1971.1.2.43
Abstract
- A double-blind trial of the efficacy of propranolol hydrochloride a new beta adrenergic blocking agent, in the prophylactic treatment of angina pectoris was conducted in 9 patients. Through the trial period of 8 weeks to more than 26 weeks, the patients received propranolol and placebo for equal period. Following are the results. 1. The effective dose of propranolol hydrochloride in the prophylactic treatment of angina pectoris was 80 mg to 120 mg per day. 2. The effectiveness of propranolol hydrochloride was manifested by a reduction in frequency of pain to 40.7%, in nitroglycerin comsumption to 38.8% and by an increase in exercise tolerance. 3. Obseved side effects were transient nausea, vomiting and bradycardia, which were improved with reduction in drug dosage. 4. Further clinical and experimental information may be necessary in order to assess the long-term effects of propranolol hydrochloride.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Antihypertensive Effect of Long-acting Propranolol(Inderal LA(R)) A Clinical study
- Diagnosis of angina pectoris
- Spinal Cord Stimulation for Refractory Angina Pectoris: A Case Report
- A Case of Polycythemia Vera Presenting with Angina Pectoris without Coronary Artery Stenosis
- Effect of Angina Pectoris before Acute Myocardial Infarction on Degree of Residual Stenosis after Successful Coronary Thrombolysis
